Archives

Targeted lung denervation (TLD) is designed to disrupt pulmonary nerve reflexes, which may have the potential to reduce COPD exacerbations. Illustration courtesy Nuvaira Inc.
UofL pulmonologists treat first local patient in COPD clinical trial Targeted lung denervation may offer new option for COPD patients
LOUISVILLE, Ky. – Physicians from the University of Louisville are the first in Kentucky to perform an investigational procedure designed to help patients with...
Archived photo of the Kentucky Women's Book Festival in 2020.
Kentucky women authors share stories of struggle and hope UofL Women’s Center sponsors 15th annual Kentucky Women’s Book Festival
A thoughtful commentary on the segregation of swimming pools and stereotypes of African Americans and swimming is told through one young woman’s journey from...
Research group releases framework for optimizing medication and vaccine outcomes through pharmacists and pharmacies
The University of Louisville Center for Health Organization Transformation (CHOT), a National Science Foundation-funded research center based at the School of Public Health and...
Research shows that an increase in daily low temperature corresponds to a decrease in COVID-19 cases
Data show lower daily temperatures lead to higher transmission of COVID-19 Research from UofL published in PLOS ONE shows effect of daily low temperatures and infection rates in 50 Northern Hemisphere countries on SARS-CoV-2 transmission
LOUISVILLE, Ky. – The SARS-CoV-2 pandemic has caused tremendous upheaval, leading to more than 2.3 million deaths worldwide and 465,000 in the United States....
MEDIA ADVISORY: UofL infectious diseases experts to discuss COVID-19 vaccines Virtual Grand Rounds presented by UofL Department of Medicine
WHO: Julio Ramirez, M.D., Chief, Division of Infectious Diseases, University of Louisville Ruth Carrico, Ph.D., D.N.P., Professor, Division of Infectious Diseases, UofL WHAT:  UofL infectious diseases experts...
Eli Lilly and Company staff conducting release and stability testing of the clinical trial materials. Photo courtesy Eli Lilly and Company
UofL tapped for Lilly monoclonal antibody trial in long-term care facilities Phase 3 clinical trial evaluating bamlanivimab for prevention of COVID-19 in response to increased exposure risk
LOUISVILLE, Ky. – Researchers from the University of Louisville are working with Eli Lilly and Company in a clinical trial to determine whether its...
Kent Oyler
Kent Oyler joins UofL College of Business as executive in residence
LOUISVILLE, Ky. – Kent Oyler has joined the University of Louisville College of Business as an executive in residence. In this role, Oyler will advise...
David Calzi, UofL director of industry partnerships
UofL hires Ernst & Young alumnus to lead industry partnerships
LOUISVILLE, Ky. — The University of Louisville has hired former longtime Ernst & Young (EY) partner David Calzi to guide industry engagement as part...
UofL Brandeis School of Law sets 2020 commencement date
LOUISVILLE, Ky. – The University of Louisville has approved a plan for the Brandeis School of Law to hold a belated ceremony for 2020 graduates...
Tendai Charasika
UofL hires tech founder, double-alumnus to guide research-backed innovations to market
LOUISVILLE, Ky. – The University of Louisville has hired alumnus, football star and seasoned tech founder Tendai Charasika to help guide innovations developed at...